- Home
- XFOR vs BIOX Comparison
XFOR vs BIOX Comparison
Compare XFOR & BIOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XFOR
- BIOX
- Stock Information
- Founded
- XFOR 2014
- BIOX 2001
- Country
- XFOR United States
- BIOX Argentina
- Employees
- XFOR N/A
- BIOX N/A
- Industry
- XFOR Biotechnology: Biological Products (No Diagnostic Substances)
- BIOX Agricultural Chemicals
- Sector
- XFOR Health Care
- BIOX Industrials
- Exchange
- XFOR Nasdaq
- BIOX Nasdaq
- Market Cap
- XFOR 84.3M
- BIOX 85.0M
- IPO Year
- XFOR N/A
- BIOX N/A
- Fundamental
- Price
- XFOR $3.81
- BIOX $2.00
- Analyst Decision
- XFOR Strong Buy
- BIOX Buy
- Analyst Count
- XFOR 3
- BIOX 3
- Target Price
- XFOR $34.17
- BIOX $4.50
- AVG Volume (30 Days)
- XFOR 1.4M
- BIOX 1.4M
- Earning Date
- XFOR 11-12-2025
- BIOX 11-12-2025
- Dividend Yield
- XFOR N/A
- BIOX N/A
- EPS Growth
- XFOR N/A
- BIOX N/A
- EPS
- XFOR N/A
- BIOX N/A
- Revenue
- XFOR $32,774,000.00
- BIOX $333,300,000.00
- Revenue This Year
- XFOR $1,307.51
- BIOX $6.77
- Revenue Next Year
- XFOR N/A
- BIOX $21.39
- P/E Ratio
- XFOR N/A
- BIOX N/A
- Revenue Growth
- XFOR 5721.31
- BIOX N/A
- 52 Week Low
- XFOR $1.35
- BIOX $1.20
- 52 Week High
- XFOR $26.83
- BIOX $7.44
- Technical
- Relative Strength Index (RSI)
- XFOR 62.18
- BIOX 57.06
- Support Level
- XFOR $2.96
- BIOX $1.82
- Resistance Level
- XFOR $4.54
- BIOX $2.19
- Average True Range (ATR)
- XFOR 0.27
- BIOX 0.25
- MACD
- XFOR 0.07
- BIOX 0.09
- Stochastic Oscillator
- XFOR 55.75
- BIOX 77.54
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
About BIOX Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.